Clinical Trials Directory

Trials / Completed

CompletedNCT06234709

Long-term Mortality After Intensive Care Considering Comorbidity and Admission Diagnoses

Comorbidity With Greatest Impact on Mortality Considering Different Admission Diagnosis and After Landmark Time in an Intensive Care Population Compared to the General Population

Status
Completed
Phase
Study type
Observational
Enrollment
200,000 (actual)
Sponsor
Anna Aronsson · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

This is a register-based study The aim of this study is to investigate how common comorbidity is in different age groups and which comorbidity that has the greatest impact on mortality considering different admission diagnosis and after the acute phase compared to the general population. Also, how different degrees of comorbidity affect mortality, adjusted for other comorbidities and SAPS 3?

Detailed description

The study population included all patients \> 16 years old admitted to an ICU during the years 2006 to 2012 and registered in the Swedish Intensive Care Registry (SIR). Hospital discharge diagnoses from in-patient care five years preceding the index time for the ICU admission were extracted from the National Patient Register (NPR) and linked to ICU admissions using unique person identity numbers. Follow-up for all-cause mortality were extracted from the cause of death register at NPR.

Conditions

Timeline

Start date
2005-01-01
Primary completion
2016-12-31
Completion
2016-12-31
First posted
2024-01-31
Last updated
2024-02-02

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT06234709. Inclusion in this directory is not an endorsement.